This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Fortune Magazine Profiles ArcView Group, Co-founded By Steve DeAngelo









OAKLAND, Calif., March 23, 2013 /PRNewswire/ -- ArcView—the ambitious, accredited cannabis investment network co-created by Steve DeAngelo—will grace the cover of Fortune Magazine March 25, 2013. The feature story gives readers an inside look at growing investor interest in one of the country's fastest emerging industries—cannabis.

In January, Fortune's senior legal analyst/reporter Roger Parloff traveled to Seattle, Washington, where he was given exclusive access to The ArcView Group's Angel Investor Network Meeting, which pairs accredited investors with vetted cannabis companies around the United States.

Cannabis industry and movement leader, Steve DeAngelo, co-founded The ArcView Group in 2010 with fellow activist/entrepreneur, Troy Dayton. The event was attended by 35 investors, who heard pitches from 12 cannabis-related companies after being welcomed by Seattle Mayor Mike McGinn.

The ArcView Group is developing a responsible, respected, profitable, and politically engaged, legal cannabis industry. In addition to the Angel Investor Network, ArcView acts as a business incubator. Other projects developed by ArcView include Cannassure Insurance Services, See Change Research, and a soon-to-be-launched crowd-funding platform, WeCanna.

Steve DeAngelo is a veteran activist and entrepreneur who has launched several successful cannabis ventures, including Harborside Health Center, the nation's largest, model medical dispensary; Steep Hill Laboratory, the nation's first and most sophisticated cannabis-testing laboratory; and Ecolution, which for a decade was America's premier industrial hemp company.

DeAngelo and Harborside have also led the way in resisting the U.S. attorneys' crackdown on regulated medical cannabis providers in California, and currently are litigating two separate lawsuits against the federal government to halt federal efforts to close medical cannabis dispensaries.

Read the full Fortune cover story here: http://money.cnn.com/2013/03/21/smallbusiness/legal-marijuana-startups.pr.fortune/

For more details about The ArcView Group, go to: arcviewgroup.com.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 17,712.66 +34.43 0.19%
S&P 500 2,061.02 +4.87 0.24%
NASDAQ 4,891.2190 +27.8570 0.57%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs